Correction for Evans et al., Informing antibiotic treatment decisions: Evaluating rapid molecular diagnostics to identify susceptibility and resistance to carbapenems against acinetobacter spp. in PRIMERS III (Journal of Clinical Microbiology (2017) 55:1 (134-144) DOI: 10.1128/JCM.01524-16);Informing antibiotic treatment decisions: Evaluating rapid molecular diagnostics to identify susceptibility and resistance to carbapenems against Acinetobacter spp. In PRIMERS III

Journal of Clinical Microbiology

Volumn 55, Issue 1, 2017, Pages 134-144

  Evans, Scott R ^a   Hujer, Andrea M ^b,c   Jiang, Hongyu ^a   Hill, Carol B ^d   Hujer, Kristine M ^b,c   Mediavilla, Jose R ^e   Manca, Claudia ^e   Tran, Thuy Tien T ^a   Domitrovic, T Nicholas ^b,c   Higgins, Paul G ^f,g   Seifert, Harald ^f,g   Kreiswirth, Barry N ^e   Patel, Robin ^h   Jacobs, Michael R ^b   Chen, Liang ^e   Sampath, Rangarajan ⁱ   Hall, Thomas ⁱ   Marzan, Christine ⁱ   Fowler, Vance G ^d   Chambers, Henry F ^j   Bonomo, Robert A ^b,c   more..

^a CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e RUTGERS UNIVERSITY   (United States)

^f UNIVERSITY OF COLOGNE   (Germany)

^g German Center for Infection Research (DZIF)   (Germany)

^h MAYO CLINIC   (United States)

ⁱ ABBOTT LABORATORIES   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Acinetobacter; Beta lactams; Carbapenemases

Indexed keywords

AMIKACIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; DORIPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; MINOCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULTAMICILLIN; TETRACYCLINE; TIGECYCLINE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE; PRIMER DNA;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER PITTII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLAOXA 23 GENE; BLAOXA 24 40 GENE; BLAOXA 58 GENE; CARBAPENEM RESISTANT ACINETOBACTER; CONTROLLED STUDY; DNA MICROARRAY; ELECTROSPRAY MASS SPECTROMETRY; GENETIC ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DIAGNOSIS; NEXT GENERATION SEQUENCING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; COMPARATIVE STUDY; DRUG EFFECTS; ENZYMOLOGY; EVALUATION STUDY; GENETICS; HUMAN; MICROBIAL SENSITIVITY TEST; MOLECULAR PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; SENSITIVITY AND SPECIFICITY; TIME FACTOR;

ACINETOBACTER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; DNA PRIMERS; HUMANS; MICROBIAL SENSITIVITY TESTS; PATHOLOGY, MOLECULAR; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 85008394504     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00525-17     Document Type: Erratum

References (21)

1. Evans SR, Hujer AM, Jiang H, Hujer KM, Hall T, Marzan C, Jacobs MR, Sampath R, Ecker DJ, Manca C, Chavda K, Zhang P, Fernandez H, Chen L, Mediavilla JR, Hill CB, Perez F, Caliendo AM, Fowler VG, Jr, Chambers HF, Kreiswirth BN, Bonomo RA. 2016. Rapid molecular diagnostics, antibiotic treatment decisions, and developing approaches to inform empiric therapy: PRIMERS I and II. Clin Infect Dis 62:181-189. https://doi.org/10.1093/cid/civ837.
2. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. 2007. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51:3471-3484. https://doi.org/10.1128/AAC.01464-06.
3. Gonzalez-Villoria AM, Valverde-Garduno V. 2016. Antibiotic-resistant Acinetobacter baumannii increasing success remains a challenge as a nosocomial pathogen. J Pathog 2016:7318075.
4. Perez F, Endimiani A, Bonomo RA. 2008. Why are we afraid of Acinetobacter baumannii? Expert Rev Anti Infect Ther 6:269-271. https://doi.org/10.1586/14787210.6.3.269.
5. Karageorgopoulos DE, Falagas ME. 2008. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 8:751-762. https://doi.org/10.1016/S1473-3099(08)70279-2.
6. Thamlikitkul V, Tiengrim S, Seenama C. 2016. Comparative in vitro activity of minocycline and selected antibiotics against carbapenemresistant Acinetobacter baumannii from Thailand. Int J Antimicrob Agents 47:101-102. https://doi.org/10.1016/j.ijantimicag.2015.11.006.
7. Figueiredo S, Poirel L, Croize J, Recule C, Nordmann P. 2009. In vivo selection of reduced susceptibility to carbapenems in Acinetobacter baumannii related to ISAba1-mediated overexpression of the natural bla(OXA-66) oxacillinase gene. Antimicrob Agents Chemother 53: 2657-2659. https://doi.org/10.1128/AAC.01663-08.
8. Zander E, Chmielarczyk A, Heczko P, Seifert H, Higgins PG. 2013. Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility. J Antimicrob Chemother 68:308-311. https://doi.org/10.1093/jac/dks382.
9. Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, Ecker DJ, Massire C, Eshoo MW, Sampath R, Thomson JM, Rather PN, Craft DW, Fishbain JT, Ewell AJ, Jacobs MR, Paterson DL, Bonomo RA. 2006. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother 50: 4114-4123. https://doi.org/10.1128/AAC.00778-06.
10. Perez F, Endimiani A, Ray AJ, Decker BK, Wallace CJ, Hujer KM, Ecker DJ, Adams MD, Toltzis P, Dul MJ, Windau A, Bajaksouzian S, Jacobs MR, Salata RA, Bonomo RA. 2010. Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. J Antimicrob Chemother 65:1807-1818. https://doi.org/10.1093/jac/dkq191.
11. Perez F, Hujer AM, Hulten EA, Fishbain J, Hujer KM, Aron D, Thweatt K, Donskey CJ, Bonomo RA. 2010. Antibiotic resistance determinants in Acinetobacter spp and clinical outcomes in patients from a major military treatment facility. Am J Infect Control 38:63-65. https://doi.org/10.1016/j.ajic.2009.05.007.
12. CLSI. 2014. Performance standards for antimicrobial susceptibility testing; 24th informational supplement. CLSI document M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA.
13. Baldwin CD, Howe GB, Sampath R, Blyn LB, Matthews H, Harpin V, Hall TA, Drader JJ, Hofstadler SA, Eshoo MW, Rudnick K, Studarus K, Moore D, Abbott S, Janda JM, Whitehouse CA. 2009. Usefulness of multilocus polymerase chain reaction followed by electrospray ionization mass spectrometry to identify a diverse panel of bacterial isolates. Diagn Microbiol Infect Dis 63:403-408. https://doi.org/10.1016/j.diagmicrobio.2008.12.012.
14. Chen L, Mediavilla JR, Endimiani A, Rosenthal ME, Zhao Y, Bonomo RA, Kreiswirth BN. 2011. Multiplex real-time PCR assay for detection and classification of Klebsiella pneumoniae carbapenemase gene (bla KPC) variants. J Clin Microbiol 49:579-585. https://doi.org/10.1128/JCM.01588-10.
15. Higgins PG, Lehmann M, Seifert H. 2010. Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 35:305. https://doi.org/10.1016/j.ijantimicag.2009.10.014.
16. Higgins PG, Perez-Llarena FJ, Zander E, Fernandez A, Bou G, Seifert H. 2013. OXA-235, a novel class D beta-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 57:2121-2126. https://doi.org/10.1128/AAC.02413-12.
17. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SG, Livermore DM. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27:351-353. https://doi.org/10.1016/j.ijantimicag.2006.01.004.
18. Higgins PG, Lehmann M, Wisplinghoff H, Seifert H. 2010. gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3. J Clin Microbiol 48:4592-4594. https://doi.org/10.1128/JCM.01765-10.
19. Higgins PG, Wisplinghoff H, Krut O, Seifert H. 2007. A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU. Clin Microbiol Infect 13:1199-1201. https://doi.org/10.1111/j.1469-0691.2007.01819.x.
20. Kamolvit W, Higgins PG, Paterson DL, Seifert H. 2014. Multiplex PCR to detect the genes encoding naturally occurring oxacillinases in Acinetobacter spp. J Antimicrob Chemother 69:959-963. https://doi.org/10.1093/jac/dkt480.
21. Zander E, Higgins PG, Fernandez-Gonzalez A, Seifert H. 2013. Detection of intrinsic blaOXA-51-like by multiplex PCR on its own is not reliable for the identification of Acinetobacter baumannii. Int J Med Microbiol 303: 88-89. https://doi.org/10.1016/j.ijmm.2012.12.007.